Optical Imaging

Company Overview

Snapshot

Founded in August 1998 by Amiram Grinvald, Optical Imaging operated with 1–10 employees. The company secured FDA approval for its technology in February 2010.

Business overview

Optical Imaging is a medical device company specializing in ophthalmic equipment for early diagnosis, targeted treatment, and monitoring of retinal and neurological conditions. The company's core technology includes the Retinal Function Imager (RFI) and Brain Imager 3001 systems, which utilize proprietary image acquisition hardware, image processing, and statistical analysis algorithms. The RFI maps retinal capillaries to the resolution of single red blood cells, providing insights into retinal disease pathogenesis, while its Voltage Sensitive Dyes (VSDs) enable high-speed neural imaging of electrical signals in the brain. Optical Imaging serves clinics, laboratories, and healthcare providers in the Health Tech & Life Sciences sector, with a focus on ophthalmology, diagnostics, and neurology.

Company Intelligence Q&A

What is Optical Imaging's primary focus?

Optical Imaging is a medical device company that develops ophthalmic equipment for early diagnosis, targeted treatment, and monitoring of retinal and neurological conditions.

What key products does Optical Imaging offer?

The company offers the Retinal Function Imager (RFI) and Brain Imager 3001 systems, alongside.

When was Optical Imaging founded?

Optical Imaging was founded in August 1998.

Who founded Optical Imaging?

Amiram Grinvald is the founder of Optical Imaging.

What was a significant regulatory milestone for Optical Imaging?

In February 2010, Optical Imaging received FDA approval for its technology, allowing it to market its ophthalmic equipment in the United States.